875.75↑-2.25 (-0.26%)
12:00 AM,22nd Sep 2023BSE : 539730
NSE :
Sector : Health care
ISIN Code : INE194R01017
Last Updated: Sep 22 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Incorported in 1987 as a private limited company Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma a proprietory firm for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993 D N Pharma's operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets capsules dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district) Maharashtra which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters including Merind.In Apr.'96 the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal Tanzaniya Uganda & Sri Lanka.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 401 |
EPS - TTM (₹) [S] | 28.17 |
P/E Ratio (X) [S] | 4.32 |
Face Value (₹) | 10 |
Latest Dividend (%) | 7.00 |
Latest Dividend Date | 22 Sep 2023 |
Dividend Yield (%) | 0.08 |
Book Value Share (₹) [S] | 202.65 |
P/B Ratio (₹) [S] | 4.32 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 855.00 887.70 |
Week Low/High | 855.00 948.00 |
Month Low/High | 846.00 1009.00 |
Year Low/High | 740.00 1428.00 |
All time Low/High | 12.50 1428.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -4.15% | % | -2.70 | -2.57% |
1 Month | -8.88% | % | 1.21 | 1.43% |
3 Month | 6.37% | % | 4.38 | 4.81% |
6 Month | 2.30% | % | 13.66 | 15.00% |
1 Year | -16.24% | % | 11.65 | 11.60% |
3 Year | 278.21% | % | 74.93 | 76.39% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
14-09-2021 | ANAND JHINGAN | BSE | SELL | 24758 | 422.48 |
14-09-2021 | ASHOK JHINGAN | BSE | SELL | 24000 | 443.07 |
01-07-2020 | KAMAL KUMAR JALAN SEC. PVT. LTD | BSE | BUY | 33872 | 184.83 |
01-07-2020 | KAMAL KUMAR JALAN SEC. PVT. LTD | BSE | SELL | 33697 | 187.30 |
01-07-2020 | SURINDER GURMUKH DHAUL | BSE | BUY | 24881 | 183.48 |
01-07-2020 | SURINDER GURMUKH DHAUL | BSE | SELL | 24881 | 186.19 |
01-07-2020 | ZAHEER . | BSE | BUY | 112025 | 186.01 |
01-07-2020 | ZAHEER . | BSE | SELL | 112025 | 183.28 |
15-01-2018 | MADHUBALA PARESH TRIVEDI | BSE | SELL | 15400 | 142.70 |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 49.33 |
Financial Institutions Banks | 1.61 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 43.49 |
Others Non Institutional Investors | 5.57 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Chairperson & Joint MD : Daulat N Medhora
Executive Director : Nariman B Medhora
Non-Exec. & Independent Dir. : Aspi N Raimalwala
Managing Director & CFO : Fredun N Medhora
Non-Exec. & Independent Dir. : Rohinton Kanga
Company Sec. & Compli. Officer : Jinkal Shah
Registered Office: 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala,Mumbai,Maharashtra-400031 Ph: 91-22-40318111
Email:business@fredungroup.com